Moleculin Biotech, Inc. Operating Cash Flow
Moleculin Biotech, Inc. (MBRX) reported Operating Cash Flow of -$12.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- Moleculin Biotech, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$6.66M.
- Moleculin Biotech, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$6.11M.
- Moleculin Biotech, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$5.37M.
- Moleculin Biotech, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$7.22M.
- Moleculin Biotech, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$22.73M.
- Moleculin Biotech, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$23.86M.
- Moleculin Biotech, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$23.59M.
- Moleculin Biotech, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$27.64M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$6.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$12.77M 10-Q · filed 2026-08-13 | -$18.13M derived: sum of 3 quarters · filed 2026-08-13 | -$25.36M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | -$6.11M 10-Q · filed 2026-05-14 | -$11.48M derived: sum of 2 quarters · filed 2026-05-14 | -$18.70M derived: sum of 3 quarters · filed 2026-05-14 | -$24.28M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | -$5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$12.59M derived: sum of 2 quarters · filed 2026-03-18 | -$18.17M derived: sum of 3 quarters · filed 2026-08-13 | -$22.73M 10-K · filed 2026-03-18 | |
| 2025-09-30 | -$7.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$12.80M derived: sum of 2 quarters · filed 2026-08-13 | -$17.37M 10-Q · filed 2025-11-13 | -$22.45M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | -$5.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$10.15M 10-Q · filed 2026-08-13 | -$15.23M derived: sum of 3 quarters · filed 2026-08-13 | -$21.34M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$4.56M 10-Q · filed 2026-05-14 | -$9.65M derived: sum of 2 quarters · filed 2026-05-14 | -$15.76M derived: sum of 3 quarters · filed 2026-05-14 | -$21.71M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | -$5.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$11.20M derived: sum of 2 quarters · filed 2026-03-18 | -$17.14M derived: sum of 3 quarters · filed 2026-03-18 | -$23.86M 10-K · filed 2026-03-18 | |
| 2024-09-30 | -$6.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$12.06M derived: sum of 2 quarters · filed 2025-11-13 | -$18.78M 10-Q · filed 2025-11-13 | -$23.68M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$5.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$12.67M 10-Q · filed 2025-08-12 | -$17.56M derived: sum of 3 quarters · filed 2025-08-12 | -$25.11M derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | -$6.72M 10-Q · filed 2025-05-13 | -$11.61M derived: sum of 2 quarters · filed 2025-05-13 | -$19.16M derived: sum of 3 quarters · filed 2025-05-13 | -$24.29M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | -$4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$12.45M derived: sum of 2 quarters · filed 2025-03-21 | -$17.57M derived: sum of 3 quarters · filed 2025-03-21 | -$23.59M 10-K · filed 2025-03-21 | -$24.10M 10-K · filed 2024-03-22 |
| 2023-09-30 | -$7.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$12.68M derived: sum of 2 quarters · filed 2024-11-08 | -$18.69M 10-Q · filed 2024-11-08 | -$25.95M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | -$5.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$11.14M 10-Q · filed 2024-08-13 | -$18.40M derived: sum of 3 quarters · filed 2024-08-13 | -$25.98M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | -$6.02M 10-Q · filed 2024-05-10 | -$13.27M derived: sum of 2 quarters · filed 2024-05-10 | -$20.85M derived: sum of 3 quarters · filed 2024-05-10 | -$28.85M derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | -$7.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$14.83M derived: sum of 2 quarters · filed 2024-03-22 | -$22.83M derived: sum of 3 quarters · filed 2024-03-22 | -$27.64M 10-K · filed 2024-03-22 | |
| 2022-09-30 | -$7.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$15.58M derived: sum of 2 quarters · filed 2023-11-13 | -$20.38M 10-Q · filed 2023-11-13 | -$24.64M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$12.81M 10-Q · filed 2023-08-10 | -$17.06M derived: sum of 3 quarters · filed 2023-08-10 | -$21.35M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | -$4.80M 10-Q · filed 2023-05-10 | -$9.06M derived: sum of 2 quarters · filed 2023-05-10 | -$13.35M derived: sum of 3 quarters · filed 2023-05-10 | -$20.13M derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | -$4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$8.55M derived: sum of 2 quarters · filed 2023-03-22 | -$15.33M derived: sum of 3 quarters · filed 2023-03-22 | -$18.95M 10-K · filed 2023-03-22 | |
| 2021-09-30 | -$4.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$11.07M derived: sum of 2 quarters · filed 2022-11-10 | -$14.69M 10-Q · filed 2022-11-10 | -$17.82M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$6.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$10.40M 10-Q · filed 2022-08-12 | -$13.53M derived: sum of 3 quarters · filed 2022-08-12 | -$18.90M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | -$3.62M 10-Q · filed 2022-05-11 | -$6.75M derived: sum of 2 quarters · filed 2022-05-11 | -$12.12M derived: sum of 3 quarters · filed 2022-05-11 | -$17.05M derived: sum of 4 quarters · filed 2022-05-11 | |
| 2020-12-31 | -$3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$8.50M derived: sum of 2 quarters · filed 2022-03-24 | -$13.43M derived: sum of 3 quarters · filed 2022-03-24 | -$17.77M 10-K · filed 2022-03-24 | |
| 2020-09-30 | -$5.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$10.30M derived: sum of 2 quarters · filed 2021-11-10 | -$14.65M 10-Q · filed 2021-11-10 | -$19.32M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$4.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$9.28M 10-Q · filed 2021-08-11 | -$13.95M derived: sum of 3 quarters · filed 2021-08-11 | -$17.28M derived: sum of 4 quarters · filed 2021-08-11 | |
| 2020-03-31 | -$4.34M 10-Q · filed 2021-05-12 | -$9.02M derived: sum of 2 quarters · filed 2021-05-12 | -$12.35M derived: sum of 3 quarters · filed 2021-05-12 | -$17.69M derived: sum of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | -$4.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | -$8.00M derived: sum of 2 quarters · filed 2021-03-24 | -$13.35M derived: sum of 3 quarters · filed 2021-03-24 | -$17.20M 10-K · filed 2021-03-24 | |
| 2019-09-30 | -$3.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$8.67M derived: sum of 2 quarters · filed 2020-11-12 | -$12.52M 10-Q · filed 2020-11-12 | -$15.63M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | -$5.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$9.19M 10-Q · filed 2020-08-12 | -$12.30M derived: sum of 3 quarters · filed 2020-08-12 | -$15.12M derived: sum of 4 quarters · filed 2020-08-12 | |
| 2019-03-31 | -$3.85M 10-Q · filed 2020-05-11 | -$6.96M derived: sum of 2 quarters · filed 2020-05-11 | -$9.78M derived: sum of 3 quarters · filed 2020-05-11 | -$13.24M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | -$3.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | -$5.93M derived: sum of 2 quarters · filed 2020-03-19 | -$9.40M derived: sum of 3 quarters · filed 2020-03-19 | -$12.20M 10-K · filed 2020-03-19 | |
| 2018-09-30 | -$2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$6.29M derived: sum of 2 quarters · filed 2019-11-12 | -$9.09M 10-Q · filed 2019-11-12 | -$11.48M derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | -$3.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-16 | -$6.27M 10-Q · filed 2019-08-16 | -$8.66M derived: sum of 3 quarters · filed 2019-08-16 | -$10.28M derived: sum of 4 quarters · filed 2019-08-16 | |
| 2018-03-31 | -$2.81M 10-Q · filed 2019-05-13 | -$5.20M derived: sum of 2 quarters · filed 2019-05-13 | -$6.81M derived: sum of 3 quarters · filed 2019-05-13 | -$8.74M derived: sum of 4 quarters · filed 2019-05-13 | |
| 2017-12-31 | -$2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | -$4.00M derived: sum of 2 quarters · filed 2019-02-21 | -$5.93M derived: sum of 3 quarters · filed 2019-02-21 | -$7.32M 10-K · filed 2019-02-21 | |
| 2017-09-30 | -$1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$3.54M derived: sum of 2 quarters · filed 2018-11-13 | -$4.93M 10-Q · filed 2018-11-13 | -$6.10M derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | -$1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$3.32M 10-Q · filed 2018-08-10 | -$4.49M derived: sum of 3 quarters · filed 2018-08-10 | ||
| 2017-03-31 | -$1.39M 10-Q · filed 2018-05-14 | -$2.56M derived: sum of 2 quarters · filed 2018-05-14 | |||
| 2016-12-31 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | -$3.77M 10-K · filed 2018-03-28 | |||
| 2016-09-30 | -$2.60M 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |